Ribosomally synthesized and post-translationally modified
peptides
(RiPPs) are a class of exponentially increased natural products with
characteristic chemical structures, topologies, and biosynthetic mechanisms
as well as exceptional bioactivities including antibacteria, antitumors,
and antiviruses. The biosynthesis of RiPP proceeds via a ribosomally
assembled precursor peptide that undergoes varied post-translational
modifications to generate a mature peptide. Cytochrome P450 (CYP or
P450) monooxygenases are a superfamily of heme-containing enzymes
that span a wide range of secondary metabolite biosynthetic pathways
due to their broad substrate scopes and excellent catalytic versatility.
In contrast to the enormous quantities of RiPPs and P450s, the P450
associated RiPP biosynthesis is comparatively limited, with most of
their functions and timings remaining mysterious. Herein, this Review
aims to provide an overview on the striking roles of P450s in RiPP
biosyntheses uncovered to date and to illustrate their remarkable
functions, mechanisms, as well as remaining challenges. This will
shed light on novel P450 discovery and characterizations in RiPP biosyntheses.